Genelux Corporation Insider Transactions
Genelux Corporation Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Szalay Aladar
10 percent owner |
Sell | 75,690 @ $25.49 | $1.93 M | 1,441,487 | 10/03/2023 | 10/04/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 2,289 @ $24.12 | $55,211 | 1,517,177 | 09/28/2023 | 09/29/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 11,257 @ $24.47 | $275,459 | 1,519,466 | 09/27/2023 | 09/29/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 7,465 @ $22.47 | $167,739 | 1,553,063 | 09/26/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 12,740 @ $24.03 | $306,142 | 1,540,323 | 09/26/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 9,600 @ $24.51 | $235,296 | 1,530,723 | 09/26/2023 | 09/27/2023 | |
|
Yu Yong
VP, Clinical Trial Operations |
Sell | 1,883 @ $22.54 | $42,442 | 109,452 | 09/26/2023 | 09/27/2023 | |
|
Yu Yong
VP, Clinical Trial Operations |
Sell | 1,114 @ $23.51 | $26,195 | 108,338 | 09/26/2023 | 09/27/2023 | |
|
Yu Yong
VP, Clinical Trial Operations |
Sell | 2,203 @ $24.46 | $53,890 | 106,135 | 09/26/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 3,947 @ $24.82 | $97,965 | 1,569,039 | 09/25/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 5,511 @ $25.75 | $141,908 | 1,563,528 | 09/25/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 1,900 @ $26.60 | $50,540 | 1,561,628 | 09/25/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 1,100 @ $27.81 | $30,591 | 1,560,528 | 09/25/2023 | 09/27/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 4,421 @ $26.88 | $118,853 | 1,577,607 | 09/22/2023 | 09/25/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 4,621 @ $27.76 | $128,270 | 1,572,986 | 09/22/2023 | 09/25/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 2,871 @ $27.89 | $80,063 | 1,586,706 | 09/21/2023 | 09/25/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 4,678 @ $28.82 | $134,815 | 1,582,028 | 09/21/2023 | 09/25/2023 | |
|
Yu Yong
VP, Clinical Trial Operations |
Sell | 6,000 @ $27.96 | $167,786 | 106,135 | 09/20/2023 | 09/21/2023 | |
|
Ryder Sean
General Counsel |
Sell | 10,000 @ $30.00 | $300,000 | 572 | 09/20/2023 | 09/21/2023 | |
|
Szalay Aladar
10 percent owner |
Sell | 23,920 @ $26.21 | $626,962 | 8,247 | 09/19/2023 | 09/20/2023 |
Genelux Corporation FAQ's
Who is on Genelux Corporation's Insider Roster?
The list of insiders at Genelux Corporation includes Szalay Aladar, Zak Lourie S., Ryder Sean, Smalling Ralph, Zindrick Thomas, Yu Yong, Mirabelli Mary, Thomas John, Smither John W, Tyree James L, Jewett Caroline, Cappello Joseph.
How much insider selling is happening at Genelux Corporation?
Insiders have sold a total of 815,988 Genelux Corporation shares in the last 12 months for a total of 2.12 M sold.
Which Genelux Corporation insiders have been selling company stock?
The following insiders have sold Genelux Corporation shares in the last 12 months: Szalay Aladar ($2.02 M), Jewett Caroline ($10,517), Ryder Sean ($11,652), Yu Yong ($14,520), Tyree James L ($4,499), Cappello Joseph ($14,742), Smalling Ralph ($5,873), Zak Lourie S. ($4,921), Zindrick Thomas ($33,497),
How much insider buying is happening at Genelux Corporation?
Insiders have purchased a total of 268,000 Genelux Corporation shares in the last 12 months for a total of 1.41 M.
Which Genelux Corporation insiders have been buying company stock?
The following insiders have purchased Genelux Corporation shares in the last 12 months: Zak Lourie S. ($164,063), Ryder Sean ($52,500), Smalling Ralph ($6,563), Zindrick Thomas ($1.05 M), Yu Yong ($13,125), Mirabelli Mary ($42,000), Thomas John ($13,125), Smither John W ($32,813), Tyree James L ($32,813),